Arcellx (ACLX)
(Delayed Data from NSDQ)
$79.98 USD
+3.56 (4.66%)
Updated Sep 18, 2025 04:00 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, Arcellx, Inc. has a market cap of $4.44B, which represents its share price of $79.98 multiplied by its outstanding shares number of 55.46M. As a mid-cap company, ACLX's shareholders are generally exposed to less risk than shareholders of small-cap companies but more risk than large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
ACLX 79.98 +3.56(4.66%)
Will ACLX be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for ACLX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ACLX
Arcellx, Inc. (ACLX) Reports Q2 Loss, Misses Revenue Estimates
Arcellx, Inc. (ACLX) Reports Q1 Loss, Lags Revenue Estimates
ACLX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Arcellx, Inc. (ACLX) Reports Q4 Loss, Lags Revenue Estimates
Adaptive Biotechnologies (ADPT) Soars 18.0%: Is Further Upside Left in the Stock?
Guardant Health (GH) Soars 6.3%: Is Further Upside Left in the Stock?
Other News for ACLX
Is ACLX positioned for a breakout? 180 Bullish Setup shows up after climbing 4.66%
Is ACLX poised for gains? Upper Bollinger Band Walk shows up after dropping 1.2%
PERCEPTIVE ADVISORS LLC Increases Stake in Kala Bio Inc
Upper Bollinger Band Walk appears for ACLX after 2.86% move
Slingshot Bullish appears for ACLX after 1.3% move